Sedative Use in the Last Week of Life and the Implications for End-of-Life Decision Making

Abstract

Sedative dose increases in the last hours of life were not associated with shortened survival overall, suggesting that the doctrine of double effect rarely has to be invoked to excuse sedative prescribing in end-stage care.